| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Wounds and Injuries | D014947 | 20 associated lipids |
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cundy T et al. | A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. | 2002 | Hum. Mol. Genet. | pmid:12189164 |
| Armstrong AP et al. | A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. | 2002 | J. Biol. Chem. | pmid:12185073 |
| Ohmori H et al. | Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. | 2002 | J. Hum. Genet. | pmid:12181640 |
| Ulrich-Vinther M et al. | Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. | 2002 | J Bone Joint Surg Am | pmid:12177271 |
| Ragab AA et al. | Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. | 2002 | Am. J. Physiol., Cell Physiol. | pmid:12176725 |
| Uemura H et al. | Serum osteoprotegerin/osteoclastogenesis-inhibitory factor during pregnancy and lactation and the relationship with calcium-regulating hormones and bone turnover markers. | 2002 | J. Endocrinol. | pmid:12176675 |
| Geoffroy V et al. | High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. | 2002 | Mol. Cell. Biol. | pmid:12167715 |
| Lorget F et al. | Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12163011 |
| Mundy GR | Metastasis to bone: causes, consequences and therapeutic opportunities. | 2002 | Nat. Rev. Cancer | pmid:12154351 |
| Hofbauer LC et al. | Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. | 2002 | Eur. J. Endocrinol. | pmid:12153751 |
| Chen XW et al. | Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12150965 |
| Grisar J et al. | Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. | 2002 | J. Rheumatol. | pmid:12136902 |
| Petersson M et al. | Oxytocin stimulates proliferation of human osteoblast-like cells. | 2002 | Peptides | pmid:12126740 |
| Sakata M et al. | Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. | 2002 | Cytokine | pmid:12126649 |
| Campagnuolo G et al. | Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis. | 2002 | Arthritis Rheum. | pmid:12124878 |
| Ziolkowska M et al. | High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment. | 2002 | Arthritis Rheum. | pmid:12124857 |
| Krane SM | Genetic control of bone remodeling--insights from a rare disease. | 2002 | N. Engl. J. Med. | pmid:12124412 |
| Whyte MP et al. | Osteoprotegerin deficiency and juvenile Paget's disease. | 2002 | N. Engl. J. Med. | pmid:12124406 |
| Biskobing DM et al. | Novel therapeutic options for osteoporosis. | 2002 | Curr Opin Rheumatol | pmid:12118183 |
| Lipton A et al. | Serum osteoprotegerin levels in healthy controls and cancer patients. | 2002 | Clin. Cancer Res. | pmid:12114435 |
| Shioi A et al. | Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. | 2002 | Circ. Res. | pmid:12114316 |
| Lee SK and Lorenzo JA | Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. | 2002 | Bone | pmid:12110442 |
| Katagiri T and Takahashi N | Regulatory mechanisms of osteoblast and osteoclast differentiation. | 2002 | Oral Dis | pmid:12108759 |
| Saidenberg Kermanac'h N et al. | Osteoprotegerin and inflammation. | 2002 Apr-Jun | Eur. Cytokine Netw. | pmid:12101070 |
| Zhang J et al. | Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. | 2002 | J. Bone Miner. Res. | pmid:12096839 |
| Langdahl BL et al. | Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. | 2002 | J. Bone Miner. Res. | pmid:12096838 |
| Koyama H et al. | Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. | 2002 | J. Bone Miner. Res. | pmid:12096835 |
| Zou W and Bar-Shavit Z | Dual modulation of osteoclast differentiation by lipopolysaccharide. | 2002 | J. Bone Miner. Res. | pmid:12096834 |
| Xing L et al. | NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. | 2002 | J. Bone Miner. Res. | pmid:12096833 |
| Price PA et al. | Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. | 2002 | J. Bone Miner. Res. | pmid:12096831 |
| Khosla S et al. | Correlates of osteoprotegerin levels in women and men. | 2002 | Osteoporos Int | pmid:12086350 |
| Kim YH et al. | Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. | 2002 | Exp. Mol. Med. | pmid:12085990 |
| Wynne F et al. | Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population. | 2002 | Calcif. Tissue Int. | pmid:12073153 |
| Nakamura H et al. | Localization of osteoprotegerin (OPG) on bone surfaces and cement lines in rat tibia. | 2002 | J. Histochem. Cytochem. | pmid:12070273 |
| Zhang J et al. | PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. | 2002 | FEBS Lett. | pmid:12067713 |
| Fu M et al. | Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12056809 |
| Penno H et al. | Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054622 |
| Wittrant Y et al. | Osteoprotegerin differentially regulates protease expression in osteoclast cultures. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054560 |
| Brändström H et al. | A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054556 |
| Sasaki N et al. | Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. | 2002 | Bone | pmid:12052453 |
| Ueland T et al. | Effects of 12 months of GH treatment on cortical and trabecular bone content of IGFs and OPG in adults with acquired GH deficiency: a double-blind, randomized, placebo-controlled study. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12050246 |
| Lossdörfer S et al. | Immunohistochemical localization of receptor activator of nuclear factor kappaB (RANK) and its ligand (RANKL) in human deciduous teeth. | 2002 | Calcif. Tissue Int. | pmid:12043011 |
| Treuheit MJ et al. | Inverse relationship of protein concentration and aggregation. | 2002 | Pharm. Res. | pmid:12033388 |
| Li X et al. | Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. | 2002 | Prostaglandins Other Lipid Mediat. | pmid:12013525 |
| Granchi D et al. | Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. | 2002 | Biomaterials | pmid:12013183 |
| Jiang Y et al. | Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. | 2002 | Infect. Immun. | pmid:12011008 |
| Iida-Klein A et al. | Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. | 2002 | J. Bone Miner. Res. | pmid:12009011 |
| Ono K et al. | Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. | 2002 | J. Bone Miner. Res. | pmid:12009007 |
| Bosshart H | Expression of survival receptors in Hodgkin disease cell lines. | 2002 | Blood | pmid:12001908 |
| de Hooge AS et al. | Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. | 2002 | Am. J. Pathol. | pmid:12000725 |